• Nie Znaleziono Wyników

Diabetes and diabetic kidney disease – an increasing epidemiological problem

N/A
N/A
Protected

Academic year: 2021

Share "Diabetes and diabetic kidney disease – an increasing epidemiological problem"

Copied!
1
0
0

Pełen tekst

(1)

186

Postępy Nauk Medycznych, t. XXVI, nr 3, 2013

©Borgis

Diabetes and diabetic kidney disease

– an increasing epidemiological problem

Economical growth, observed in most countries (e.g. China, India and many others) and even in whole con-tinents (like Africa) that were previously regarded as undeveloped and poor, resulted in an increase of global prevalence of obesity, and subsequently of increasing incidence and prevalence of diabetes. Published in 2011 prognosis predict that the prevalence of diabetes of half a billion patients in the year 2030.

Therefore, one can predict that also the number of patients with diabetic kidney disease (or diabetic neph-ropathy) will increase, even if the relative incidence will decrease (i.e. the percentage of subjects with this com-plication will be decreasing) as a result of improved treatment and prophylaxy. However, at the moment even the relative prevalence is high, exceeding 40% of patients with diabetes (1-3). As chronic kidney disease (diabetic and non-diabetic) is associated with increased cardiovascular risk (4, 5), one can also predict that cardiovascular mortality and iprevalence of other cardiovascular outcomes may increase.

This is the reason for that, that diabetes and diabetic kidney disease were chosen for this issue of „Progress of Medical Science”.

It was of course not possibile to address in one issue all the problems connected with diabetic kidney disease. It seems however that early screening and diagnosis, determinating later treatment, are of utmost importance. I would like to encourage the Readers to perform a screening of diabetic kidney disease. It should be done in order to search for increased urinary albumin excretion as well as for early loss of kidney function (glomerular filtration rate).

The principles of monitoring and screening of patients with diabetes are precised in the Guidelines of Polish Society of Diabetology, reading of which I would like to recommend (6), and in case of shortage of time they may be also found at www.cukrzyca.info.pl, where you can check for a solution of any problem connected with diabetes or diabetic kidney disease.

I wish you an interesting reading Edward Franek

B I B l I o G R A P H y

1. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: General Information and National Esti-mates on Chronic Kidney Disease in the United States, 2010. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm. Accessed November 14, 2012.

2. Koro CE, lee BH, Bowlin SJ: Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther 2009; 31(11): 2608-2617.

3. Thomas MC, Weekes AJ, Broadley oJ et al.: The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRoN study). Med J Aust 2006; 185(3): 140-144.

4. Go AS, Chertow GM, Fan D et al.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351(13): 1296-1305.

5. So Wy, Kong AP, Ma RC et al.: Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006; 29(9): 2046-2052.

Cytaty

Powiązane dokumenty

Its reduced concentration is associated with a higher risk of developing and progressive course of DKD NF-kB — nuclear factor kappa B; ESRD — end-stage renal disease; T2DM — type

Regarding severity of retinopathy (Table 2) the three subgroups were comparable regarding different parameters without statistically significant difference except for UACR that

Cukrzycowa choroba nerek określa powikłanie cuk- rzycy, które w wyniku utrzymującej się hiperglikemii doprowadza do zaburzeń czynności i zmian morfolo- gicznych w

Zakładając, że sama cukrzyca nie chroni przed rozwojem niewydolności nerek z innych przyczyn, można szacunkowo ocenić, że u około 10% chorych na cukrzycę po 60 roku życia

Większość dotychczasowych badań wskazuje, że AF zwiększa i tak już wysokie ryzyko wystąpienia udaru nie- dokrwiennego mózgu u pacjentów hemodializowanych oraz jest

Inhibitory DPP-4 mogą być stosowane u chorych we wszystkich stadiach PChN oraz u pacjentów dializowanych [4, 5, 12].. Z powodzeniem

U pacjentów z CKD ten związek jest niepewny, natomiast u osób dializowanych podwyższone stężenie CRP wiąże się z większą śmiertelno­?. ścią z różnych przyczyn

W przypadku dodatniego wyniku testu GDH należy potwierdzić lub wykluczyć zdolność bakterii do wytwarzania toksyn (w wielu labo- ratoriach test na obecność toksyn wykonuje się